Loading Events

« All Events

  • This event has passed.

Accelerating Discovery & Innovation with Immunosequencing

May 13, 2021 @ 1:00 pm - 2:00 pm

Presented by Adaptive Biotechnologies and the BRCF Advanced Genomics Core

About this Event

Seminar Topics:

  • Understand how quantitative assessments of T- and B-cell clonality and diversity can advance your pre-clinical or translational research
  • Learn about the versatility of the immunoSEQ® Assay (available through our Service or Kit), accessible to a wide variety of sample types, including FFPE tissue
  • See case studies of the immunoSEQ Technology in the context several therapeutic areas including oncology, infectious disease, autoimmune disease, and transplantation.

		Accelerating Discovery & Innovation with Immunosequencing image


Guest Speaker:
Matt Knight, PhD
Scientific Liaison, Adaptive Biotechnologies

About Dr. Knight:
Dr. Matt Knight has 10 years of research experience in immunology and infectious disease. His current role at Adaptive is focused on helping academic research clients incorporate immunoSEQ Technology into research projects and clinical trials by consulting on everything from experimental design to data analysis.


For questions or more information regarding the event, please contact: Nicole Gross at ngross@adaptivebiotech.com.

About the Advanced Genomics Core:

The Biomedical Research Core Facilities (BRCF) Advanced Genomics Core mission is to facilitate research in cutting-edge fields of genetics and genomics by implementing complex technologies. Chief among these is “next-generation” sequencing (NGS), which has revolutionized research in virtually all biological fields in the past decade. By housing NGS and companion genomic technologies in a single facility, we provide centralized expertise in advanced methods that enables all researchers to effectively exploit them for making scientific discoveries.

Translate »